How to ensure accurate NeuroQuant® processing results

In this post, I review additional causes affecting goodness of fit which can result in NeuroQuant being unable to segment specific brain structures and issuing a processing error message. Previous posts discussed why contrast agents are not used to achieve quality segmentation with NeuroQuant, and examined why good alignment to atlas is necessary for accurate NeuroQuant output.

Ensuring proper processing is an important factor in NeuroQuant’s analysis process. To achieve its high quality segmentation results, NeuroQuant verifies each patient’s brain image can be processed correctly. This safeguards the accuracy of the segmentation results and therefore, the accuracy of the calculated volumes.

Patients who have shunts, implants or other artifacts or inherent abnormalities, can potentially generate segmentation misregistration. To prevent such errors and protect the accuracy of the results, NeuroQuant prevents analysis when such artifacts or anatomical anomalies are present.

In some cases, such as the first example below, a shunt in the patient’s brain made good alignment to atlas impossible, resulting in a processing failure.

Cortechs.ai | How to ensure accurate NeuroQuant<sup>®</sup> processing resultsIn the second example, a patient’s excess cranial tissue prevented proper processing and resulted in an error message.

Cortechs.ai | How to ensure accurate NeuroQuant<sup>®</sup> processing resultsMore information about using and processing NeuroQuant can be found here.

Insights

02/02/2025

NeuroQuant® Brain Tumor: Revolutionizing Neuro-Oncology with AI-Driven Precision

Dr. Suzie Bash and Dr. Jeff Rudie dive deep into the advanced functionalities and clinical benefits of the tool that is revolutionizing neuro-oncology

01/28/2025

Revolutionizing Imaging Diagnostics with Cortechs.ai CEO, Kyle Frye

Hear from CEO Kyle Frye on the SCALE Community Podcast about how Cortechs.ai is transforming healthcare with cutting-edge AI-powered medical imaging solutions.

01/09/2025

Cortechs.ai Announces Oversubscribed Funding Round to Accelerate Innovation in AI-Powered Neuroimaging and Oncology Solutions

This investment propels our mission to revolutionize medical imaging in neuroimaging and oncology, enhancing diagnostic confidence and patient outcomes.
Scroll to Top